OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PFX$39.5058

PhenixFIN Corp

Closed End FundsVerified

PhenixFIN Corp maintains a market price of $39.5 per share, with a market capitalization of $78.93 million. The company's price-to-earnings ratio is 14.69, and its price-to-book ratio is 0.51, indicating a discount to its book value. The company's liquidity position is characterized as medium, with $19.12 million in cash and equivalents, but a debt-to-equity ratio of 0.55 suggests moderate leverage. The company's profitability is reflected in a return on equity of 3.48% and a return on assets of 2.17%. These figures are below the typical performance metrics for the capital markets industry, suggesting that the company may not be generating returns at the same level as its peers. The operating income of $571,320 and net income of $5.37 million indicate a relatively modest profit margin compared to its total assets of $247.69 million. PhenixFIN Corp's revenue is concentrated in a single business segment, as disclosed in its financial statements. The company's geographic exposure is not explicitly detailed, but its operations are primarily within the capital markets industry. The lack of segment diversification may increase its vulnerability to market-specific risks. The company's growth trajectory is uncertain, with a mean EPS estimate of -$0.94 for the upcoming period, contrasting with the last actual EPS of $2.06. This suggests a potential decline in earnings. The absence of strong buy or buy recommendations from analysts, with only one hold recommendation, indicates a cautious outlook on the company's future performance. The risk assessment for PhenixFIN Corp highlights a medium liquidity risk and a low dilution risk. However, the company's net cash position is negative after subtracting total debt, which could affect its ability to meet short-term obligations. The dilution risk is considered low, with no significant dilution potential in the near term. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's financial statements and analyst estimates provide the most recent insights into its performance and outlook. There are no notable transcripts or filings that suggest a significant shift in the company's direction or strategy.

30-day price · PFX(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyPhenixFIN Corp
TickerPFX.O
SectorFinancials
BusinessCollective Investments
Industry groupCollective Investments
IndustryClosed End Funds
AI analysis

Business. PhenixFIN Corp operates as a closed-end fund in the financial services industry, generating income primarily through investment activities in capital markets.

Classification. PhenixFIN Corp is classified under the Financials economic sector, Collective Investments business sector, and Closed End Funds industry with a confidence level of 0.92 based on verified market data.

PhenixFIN Corp maintains a market price of $39.5 per share, with a market capitalization of $78.93 million. The company's price-to-earnings ratio is 14.69, and its price-to-book ratio is 0.51, indicating a discount to its book value. The company's liquidity position is characterized as medium, with $19.12 million in cash and equivalents, but a debt-to-equity ratio of 0.55 suggests moderate leverage. The company's profitability is reflected in a return on equity of 3.48% and a return on assets of 2.17%. These figures are below the typical performance metrics for the capital markets industry, suggesting that the company may not be generating returns at the same level as its peers. The operating income of $571,320 and net income of $5.37 million indicate a relatively modest profit margin compared to its total assets of $247.69 million. PhenixFIN Corp's revenue is concentrated in a single business segment, as disclosed in its financial statements. The company's geographic exposure is not explicitly detailed, but its operations are primarily within the capital markets industry. The lack of segment diversification may increase its vulnerability to market-specific risks. The company's growth trajectory is uncertain, with a mean EPS estimate of -$0.94 for the upcoming period, contrasting with the last actual EPS of $2.06. This suggests a potential decline in earnings. The absence of strong buy or buy recommendations from analysts, with only one hold recommendation, indicates a cautious outlook on the company's future performance. The risk assessment for PhenixFIN Corp highlights a medium liquidity risk and a low dilution risk. However, the company's net cash position is negative after subtracting total debt, which could affect its ability to meet short-term obligations. The dilution risk is considered low, with no significant dilution potential in the near term. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's financial statements and analyst estimates provide the most recent insights into its performance and outlook. There are no notable transcripts or filings that suggest a significant shift in the company's direction or strategy.
Key takeaways
  • PhenixFIN Corp trades at a discount to book value with a price-to-book ratio of 0.51.
  • The company's return on equity of 3.48% is below the typical performance metrics for the capital markets industry.
  • The company's liquidity position is characterized as medium, with a debt-to-equity ratio of 0.55.
  • Analysts have issued a single hold recommendation, with no strong buy or buy recommendations.
  • The company's net cash position is negative after subtracting total debt, which could affect its ability to meet short-term obligations.
  • The company's growth trajectory is uncertain, with a mean EPS estimate of -$0.94 for the upcoming period.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$4.7M
Gross profit$3.1M
Operating income$571.3k
Net income$5.4M
R&D
SG&A
D&A
SBC
Operating cash flow$15.7M
CapEx
Free cash flow
Total assets$247.7M
Total liabilities$93.4M
Total equity$154.3M
Cash & equivalents$19.1M
Long-term debt$84.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$32.3M$18.4M$1.3M
FY-3$15.5M$3.1M-$6.1M
FY-2$20.1M$6.5M$26.9M
FY-1$22.2M$4.7M$18.6M
FY0$25.3M$5.1M$4.2M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$225.1M$143.7M$69.4M
FY-3$218.9M$120.8M$22.8M
FY-2$239.7M$146.7M$6.0M
FY-1$302.8M$160.3M$67.6M
FY0$316.9M$160.8M$7.3M
PeriodOCFCapExFCFSBC
FY-4$95.1M
FY-3-$29.3M
FY-2-$20.7M
FY-1$16.1M
FY0-$67.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$4.7M$571.3k$5.4M
FQ-6$6.2M$2.0M$2.6M
FQ-5$5.6M$473.5k$6.1M
FQ-4$6.2M$1.6M$2.5M
FQ-3$6.0M$966.0k-$896.1k
FQ-2$6.2M$1.2M-$1.5M
FQ-1$6.9M$1.4M$4.1M
FQ0$6.7M$2.1M-$4.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$247.7M$154.3M$19.1M
FQ-6$246.3M$154.2M$8.9M
FQ-5$302.8M$160.3M$67.6M
FQ-4$311.9M$162.8M$7.2M
FQ-3$300.7M$159.0M$8.7M
FQ-2$306.8M$156.7M$7.3M
FQ-1$316.9M$160.8M$7.3M
FQ0$307.4M$155.8M$3.4M
PeriodOCFCapExFCFSBC
FQ-7$15.7M
FQ-6$7.4M
FQ-5$16.1M
FQ-4-$66.3M
FQ-3-$57.5M
FQ-2-$64.4M
FQ-1-$67.3M
FQ0-$2.0M
Valuation
Market price$39.50
Market cap$78.9M
Enterprise value$144.2M
P/E14.7
Reported non-GAAP P/E
EV/Revenue31.0
EV/Op income252.4
EV/OCF9.2
P/B0.5
P/Tangible book0.5
Tangible book$154.3M
Net cash-$65.3M
Current ratio
Debt/Equity0.6
ROA2.2%
ROE3.5%
Cash conversion2.9%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Closed End Funds · cohort 5 companies
MetricPFXActivity
Op margin12.3%63.2% medp25 39.8% · p75 88.3%bottom quartile
Net margin115.3%71.0% medp25 12.8% · p75 89.3%top quartile
Gross margin66.4%76.7% medp25 50.4% · p75 92.6%below median
CapEx / revenue-3.8% medp25 -7.7% · p75 -0.9%
Debt / equity55.0%1.5% medp25 0.0% · p75 68.2%above median
Observations
IR observations
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.94 USD
Last actual EPS2.06 USD
Mean revenue estimate23,510,000 USD
Last actual revenue25,262,320 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 15:23 UTC#2e5fa1cd
Market quoteclose USD 40.72 · shares 0.00B diluted
no public URL
2026-05-16 15:24 UTC#bc5a32cf
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 23:16 UTCJob: 5eae3dee